Thu, May 7, 2020
Wed, May 6, 2020
Tue, May 5, 2020

Eric Joseph Maintained (AKBA) at Buy with Increased Target to $18 on, May 6th, 2020


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. with-increased-target-to-18-on-may-6th-2020.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Eric Joseph of JP Morgan, Maintained "Akebia Therapeutics, Inc." (AKBA) at Buy with Increased Target from $13 to $18 on, May 6th, 2020.

Eric has made no other calls on AKBA in the last 4 months.



There is 1 other peer that has a rating on AKBA. Out of the 1 peers that are also analyzing AKBA, 0 agree with Eric's Rating of Hold.



This is the rating of the analyst that currently disagrees with Eric


  • Chad Messer of "Needham" Maintained at Strong Buy with Increased Target to $18 on, Tuesday, May 5th, 2020

Publication Contributing Sources